Contract HHSN269201300825U
Regeneron Pharmaceuticals Inc · Department Of Health And Human Services · September 27, 2013
Regeneron Pharmaceuticals Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 27, 2013 for $14,000 of work in pharmaceutical preparation manufacturing. Performance is in Bethesda, MD. This is a task or delivery order issued under parent IDIQ V797P5035B. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- HHSN269201300825U
- Parent IDIQ
- V797P5035B
- Award type
- Do
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Bethesda, MD
- First action
- September 27, 2013
Description
ASD SPECIALTY HEALTHCARE INC:1107102 [13-016790]- ACCOUNT #71740
Modification timeline
-
September 27, 2013Base award$14.1K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN269201300825U?
Contract HHSN269201300825U is a federal contract awarded to Regeneron Pharmaceuticals Inc by Department Of Health And Human Services on September 27, 2013 for $14,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract HHSN269201300825U?
Regeneron Pharmaceuticals Inc won contract HHSN269201300825U from Department Of Health And Human Services.
How much is contract HHSN269201300825U worth?
Contract HHSN269201300825U has obligated $14,000 to date.